Dr. Dmitriy Zamarin speaks with Cancer Network about the findings of a phase II trial in platinum-resistant ovarian cancer patients.
Dmitriy Zamarin, MD, PhD
Advertisement
Articles by Dmitriy Zamarin, MD, PhD
In this review, we will summarize clinical trials that have used various immunotherapeutic strategies, with a particular focus on recently emerging data for new agents and combinations.
Advertisement
Latest Updated Articles
Immunotherapy: New Strategies for the Treatment of Gynecologic MalignanciesPublished: January 16th 2016 | Updated:
Target Folate Receptor Alpha in Ovarian Cancer?Published: September 17th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
FDA Approves Revumenib in R/R NPM1-Mutant AML
3
Convergent and Divergent Signaling Pathways in Cancer: A Dual-Axis Model for Adaptive Precision Oncology
4
Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment
5
